Scribe Therapeutics, Inc. (SCTX) stock
Close on Nov 11, 2026Market cap $41.90MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $41.90M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- -$66.58
- Diluted shares
- 2M
Trading
- Previous close
- $17.36
- Open
- $17.50
- Day's range
- $16.70 – $17.77
- Volume
- 369,808
- Average volume (20 days)
- 363,927
- RSI (14 days)
- 44.8
- Relative volume
- 1.00×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SCTX | S&P 500 | Difference | SCTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -20.4% | -2.4% | −17.9 pts | ||
| 3 months | -28.1% | -1.2% | −26.9 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Scribe Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
Scribe Therapeutics stock: common questions
What is Scribe Therapeutics's stock price?
SCTX closed at $16.86 on Nov 11, 2026, down 2.88% on the day.
What is Scribe Therapeutics's market cap?
Scribe Therapeutics was worth $41.90M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
Does Scribe Therapeutics pay a dividend?
No. Scribe Therapeutics has not paid a cash dividend over the last twelve months.
Who are Scribe Therapeutics's competitors?
Companies most similar to Scribe Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?